Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Annalisa
Annalisa Airoldi, Nosate (milan) IT
| Patent application number | Description | Published |
|---|---|---|
| 20090291953 | PHARMACEUTICAL SALTS OF REBOXETINE - The present invention relates to novel crystalline, water-soluable salts of the 2S,3S enantiomer of reboxetine, which are the fumarate and succinate salts thereof, to a process for their preparation, to their utility in therapy and to pharmaceutical compositions containing them. | 11-26-2009 |
Annalisa Airoldi, Nosate (mi) IT
| Patent application number | Description | Published |
|---|---|---|
| 20120041007 | CDK INHIBITOR SALTS - The present invention relates to novel crystalline form(s) of water-soluble salts and of free base of a cdk inhibitor. Such crystal salts are for example fumarate, L-malate, maleate, succinate, adipate, malonate, glycolate, phosphate, mesylate, L-lactate, hydrochloride, di-hydrochloride, tri-hydrochloride. Hydrates and polymorphs of such new salt forms, a process for their preparation, their utility in therapy and to the pharmaceutical compositions containing them are also claimed and described in the present application. | 02-16-2012 |
Annalisa Capanni, Prato IT
| Patent application number | Description | Published |
|---|---|---|
| 20110038067 | PREFERABLY MINIATURIZED OPTICAL TRANSFER DEVICE - An optical transfer device comprises at least three mirrors, two of which co-operating with one another for modifying the wave front of an electromagnetic radiation, wherein at least two of said mirrors are made monolithically on a single support. | 02-17-2011 |
| 20110038068 | OPTICAL PROBE PREFERABLY FOR SPECTROMETRIC ANALYSES - A probe comprises an external casing, an optical illumination circuit, and an optical reception circuit, at least one of which has a first concave primary mirror, a first convex secondary mirror configured for receiving a spectrum from and sending the spectrum to said first concave primary mirror, and an active optical mirror element set in series with said first concave primary mirror and said first convex secondary mirror and having a curvature such as to differentiate the optical arms of the conjugate points, a first conjugate point being inside the external casing and a second conjugate point being outside the external casing. | 02-17-2011 |
Annalisa Cappellani, Portland, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20090261391 | Complementary Metal Oxide Semiconductor Integrated Circuit Using Raised Source Drain and Replacement Metal Gate - A complementary metal oxide semiconductor integrated circuit may be formed with a PMOS device formed using a replacement metal gate and a raised source drain. The raised source drain may be formed of epitaxially deposited silicon germanium material that is doped p-type. The replacement metal gate process results in a metal gate electrode and may involve the removal of a nitride etch stop layer. | 10-22-2009 |
| 20110147842 | MULTI-GATE SEMICONDUCTOR DEVICE WITH SELF-ALIGNED EPITAXIAL SOURCE AND DRAIN - A channel strained multi-gate transistor with low parasitic resistance and method of manufacturing the same. A gate stack may be formed over a semiconductor fin having a gate-coupled sidewall height (H | 06-23-2011 |
Annalisa Ciocchetti, Novara IT
| Patent application number | Description | Published |
|---|---|---|
| 20100028935 | CONVEX BOTTOM MICROWELL - Convex-bottom microwells for laboratory use in optical analyses of colorimetric or enzymological type useful for avoiding interferences with the luminous beam of the detecting instrument by corpuscular elements present in the sample to be analysed. | 02-04-2010 |
Annalisa Delnevo, Sant' Agata Bolognese IT
| Patent application number | Description | Published |
|---|---|---|
| 20080214981 | Extracorporeal Blood Set - A blood set comprises an arterial line having a patient end provided with a multiport connector ( | 09-04-2008 |
Annalisa Macagno, Bellinzona CH
| Patent application number | Description | Published |
|---|---|---|
| 20080213265 | HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF - The invention relates to neutralising antibodies which are specific for human cytomegalovirus and bind with high affinity as well as immortalised B cells that produce such antibodies. The invention also relates to the epitopes that the antibodies bind to as well as the use of the antibodies and the epitopes in screening methods as well as the diagnosis and therapy of disease. | 09-04-2008 |
| 20090081230 | HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF - The invention relates to neutralizing antibodies and antibody fragments having high potency in neutralizing hCMV, wherein said antibodies and antibody fragments are specific for a combination of hCMV proteins UL130 and UL131A, or for a combination of hCMV proteins UL128, UL130 and UL131A. The invention relates also to immortalized B cells that produce, and to epitopes that bind to, such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies, antibody fragments, and epitopes in screening methods as well as in the diagnosis and therapy of disease. | 03-26-2009 |
| 20100092481 | HUMAN CYTOMEGALOVIRUS NEUTRALISING ANTIBODIES AND USE THEREOF - The invention relates to neutralizing antibodies, and antibody fragments thereof, having high potency in neutralizing hCMV, wherein said antibodies and antibody fragments are specific for one, or a combination of two or more, hCMV gene UL products. The invention also relates to immortalized B cells that produce, and to epitopes that bind to, such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies, antibody fragments, and epitopes in screening methods as well as in the diagnosis, prevention, and therapy of disease. | 04-15-2010 |
Annalisa Macagno, Schilieren CH
| Patent application number | Description | Published |
|---|---|---|
| 20110268746 | HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF - The invention relates to neutralizing antibodies, and antibody fragments thereof, having high potency in neutralizing hCMV, wherein said antibodies and antibody fragments are specific for one, or a combination of two or more, hCMV gene UL products. The invention also relates to immortalized B cells that produce, and to epitopes that bind to, such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies, antibody fragments, and epitopes in screening methods as well as in the diagnosis, prevention, and therapy of disease. | 11-03-2011 |
Annalisa Malfatto, Parma IT
| Patent application number | Description | Published |
|---|---|---|
| 20110233376 | MODULAR SUPPORT STRUCTURE AND MODULE THEREOF FOR CONTAINER HANDLING MACHINES | 09-29-2011 |
Annalisa Onori, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20100216712 | NUCLEIC ACID CODIFYING FOR A UTROPHIN TRANSCRIPTION SPECIFIC REGULATING PROTEIN, PROTEIN CODIFIED THEREBY AND USES THEREOF - The present invention relates to a nucleic acid molecule comprising a nucleotide sequence codifying for a protein characterized in having at least four zinc finger domains and in modulating the transcription of the utrophin gene by binding to a nucleotidic sequence comprised in a utrophin gene untranscribed regulatory sequence. Protein codified thereby and uses thereof. | 08-26-2010 |
Annalisa Sforzini, Bologna IT
| Patent application number | Description | Published |
|---|---|---|
| 20090081133 | Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations - Mucoadhesive and controlled release formulations consisting of aqueous solutions containing 0.05% to 5% by weight of a natural purified polymer having xyloglucan structure and 10% to 70% by weight of glycerol. These formulations are suitable for the application on human mucous membranes, such as nasal, oral and vaginal mucous membranes, as moisturizing and softening agents or as pharmaceutical release system. Further objects of the invention are pharmaceutical formulations and medical devices suitable for the application to human mucous membranes, containing the mucoadhesive and controlled release formulations together with active ingredients and excipients. | 03-26-2009 |
Annalisa Tomasetta, Mirobbiate IT
| Patent application number | Description | Published |
|---|---|---|
| 20100022252 | METHOD OF AND DEVICE FOR AIR TIME MANAGEMENT IN MULTI-ACCESS CHANNEL NETWORKS - An air time management method and apparatus for multi-access channel networks is provided, suitable for use when terminal stations operate with adaptive modulation. A specific modulation (default modulation) is defined for each terminal station (in a planning phase. During operation, when bandwidth is to be allotted to an uplink or downlink communication, a base station checks whether the concerned terminal station is operating with a modulation more robust (e.g. less efficient) than the default modulation. In so, the base station allocates a time slot to the communication that has a duration sufficient for transmitting less than all of a particular set of data with the default modulation. If not, the base station allocates a time slot to the communication that has a duration sufficient for transmitting all of a particular set of data with the current modulation. | 01-28-2010 |